SWOT Analysis for Madrigal Pharmaceuticals Inc

Add SWOT widget to your site/app

Positive Breakout Third Resistance ( LTP > R3)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
High Normalized Momentum Score
Consistent Highest Return Stocks over Five Years
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
PEG lower than Industry PEG
New 52 week high today
Relative Outperformance versus Industry over 10 Years
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Positive Breakout (LTP > R2)
Positive breakout third resistance ( LTP > R3)
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Stock gained more than 20% in one month
Book Value per share Improving for last 2 years
Positive Breakout (LTP > R1)
Top Gainers
Stock with Low PE (PE < = 10)
Volume Shockers
High Volume, High Gain
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter

Positive Breakout Third Resistance ( LTP > R3)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

High Normalized Momentum Score

Consistent Highest Return Stocks over Five Years

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

PEG lower than Industry PEG

New 52 week high today

Relative Outperformance versus Industry over 10 Years

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Positive Breakout (LTP > R2)

Positive breakout third resistance ( LTP > R3)

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Stock gained more than 20% in one month

Book Value per share Improving for last 2 years

Positive Breakout (LTP > R1)

Top Gainers

Stock with Low PE (PE < = 10)

Volume Shockers

High Volume, High Gain

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding
Companies with growing costs YoY for long term projects
Momentum Trap (DVM)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years

Promoter decreasing their shareholding

Companies with growing costs YoY for long term projects

Momentum Trap (DVM)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Low durability companies

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Low Piotroski Score : Companies with weak financials

Annual net profit declining for last 2 years

Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Institutions decreased their shareholding last quarter

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Institutions decreased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Madrigal Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Madrigal Pharmaceuticals Inc has 31 Strengths, 8 Weaknesses, 0 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential